Burlulipase

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBurlulipase
Drug Alias NameBacterial lipaseProject BaLiBurkholderia bacterial lipaseBaLiLU-70274 +[7] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionTriglyceride modulatorsEnzyme replacements
TargetsTriglyceride
Therapy Area/IndicationsLung DiseasesRespiratory Tract DiseasesExocrine Pancreatic Insufficiency +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNordmark Arzneimittel
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNordmark Arzneimittel Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsLung DiseasesRespiratory Tract DiseasesExocrine Pancreatic Insufficiency +[5] 

Other Information

ATC CodeN/A
Related LinksN/A